151 related articles for article (PubMed ID: 38562164)
1. Budget impact of the Walk With Ease program for knee osteoarthritis.
Kumara MT; Cleveland RJ; Kostic AM; Weisner SE; Allen KD; Golightly YM; Welch H; Dale M; Messier SP; Hunter DJ; Katz JN; Callahan LF; Losina E
Osteoarthr Cartil Open; 2024 Jun; 6(2):100463. PubMed ID: 38562164
[TBL] [Abstract][Full Text] [Related]
2. Walk with ease for knee osteoarthritis: A cost-effectiveness analysis.
Zimmerman ZE; Cleveland RJ; Kostic AM; Leifer VP; Weisner SE; Allen KD; Golightly YM; Welch H; Dale M; Messier SP; Hunter DJ; Katz JN; Callahan LF; Losina E
Osteoarthr Cartil Open; 2023 Sep; 5(3):100368. PubMed ID: 37234863
[TBL] [Abstract][Full Text] [Related]
3. Budget Impact of Funding an Intensive Diet and Exercise Program for Overweight and Obese Patients With Knee Osteoarthritis.
Smith KC; Losina E; Messier SP; Hunter DJ; Chen AT; Katz JN; Paltiel AD
ACR Open Rheumatol; 2020 Jan; 2(1):26-36. PubMed ID: 31943972
[TBL] [Abstract][Full Text] [Related]
4. The Budget Impact of Including Necitumumab on the Formulary for First-Line Treatment of Metastatic Squamous Non-Small Cell Lung Cancer: U.S. Commercial Payer and Medicare Perspectives.
Bly CA; Molife C; Brown J; Tawney MK; Carter GC; Cinfio FN; Klein RW
J Manag Care Spec Pharm; 2018 Jun; 24(6):534-543. PubMed ID: 29799326
[TBL] [Abstract][Full Text] [Related]
5. Structured Education and Neuromuscular Exercise Program for Hip and/or Knee Osteoarthritis: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2018; 18(8):1-110. PubMed ID: 30443280
[TBL] [Abstract][Full Text] [Related]
6. Budget Impact Analysis of REBYOTA™ (Fecal Microbiota, Live-jslm [FMBL]) for Preventing Recurrent Clostridioides difficile Infection in the US.
Lodise T; Guo A; Yang M; Cook EE; Song W; Yang D; Wang Q; Zhao A; Bochan M
Adv Ther; 2023 Jun; 40(6):2801-2819. PubMed ID: 37093360
[TBL] [Abstract][Full Text] [Related]
7. Budget-Impact Analysis of Alternative Herpes Zoster Vaccine Strategies: A U.S. HMO Perspective.
Graham J; Mauskopf J; Kawai K; Johnson KD; Xu R; Acosta CJ
J Manag Care Spec Pharm; 2016 Jul; 22(7):872-88. PubMed ID: 27348287
[TBL] [Abstract][Full Text] [Related]
8. Budgetary Impact of Cabazitaxel Use After Docetaxel Treatment for Metastatic Castration-Resistant Prostate Cancer.
Flannery K; Drea E; Hudspeth L; Corman S; Gao X; Xue M; Miao R
J Manag Care Spec Pharm; 2017 Apr; 23(4):416-426. PubMed ID: 28345444
[TBL] [Abstract][Full Text] [Related]
9. Estimated Budget Impact of Increased Use of Mirabegron, A Novel Treatment for Overactive Bladder.
Perk S; Wielage RC; Campbell NL; Klein TM; Perkins A; Posta LM; Yuran T; Klein RW; Ng DB
J Manag Care Spec Pharm; 2016 Sep; 22(9):1072-84. PubMed ID: 27579830
[TBL] [Abstract][Full Text] [Related]
10. Budget impact of oral nirmatrelvir/ritonavir in adults at high risk for progression to severe COVID-19 in the United States.
Sandin R; Veenstra DL; Vankelegom M; Dzingina M; Sullivan SD; Campbell D; Ma C; Harrison C; Draica F; Wiemken TL; Mugwagwa T
J Manag Care Spec Pharm; 2023 Dec; 29(12):1290-1302. PubMed ID: 38058141
[TBL] [Abstract][Full Text] [Related]
11. Intra-articular viscosupplementation with hylan g-f 20 to treat osteoarthritis of the knee: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(10):1-66. PubMed ID: 23074461
[TBL] [Abstract][Full Text] [Related]
12. The budget impact of adding pralsetinib to a US health plan formulary for treatment of non-small cell lung cancer and thyroid cancer with
Duff S; Bargiacchi F; Norregaard C; Brener M; Sullivan E
J Manag Care Spec Pharm; 2022 Feb; 28(2):218-231. PubMed ID: 34726500
[No Abstract] [Full Text] [Related]
13. The EPIPHA-KNEE trial: Explaining Pain to target unhelpful pain beliefs to Increase PHysical Activity in KNEE osteoarthritis - a protocol for a multicentre, randomised controlled trial with clinical- and cost-effectiveness analysis.
Stanton TR; Braithwaite FA; Butler D; Moseley GL; Hill C; Milte R; Ratcliffe J; Maher C; Tomkins-Lane C; Pulling BW; MacIntyre E; Esterman A; Stanford T; Lee H; Fraysse F; Metcalf B; Mouatt B; Bennell K
BMC Musculoskelet Disord; 2021 Aug; 22(1):738. PubMed ID: 34454458
[TBL] [Abstract][Full Text] [Related]
14. Randomised controlled trial of the cost-effectiveness of water-based therapy for lower limb osteoarthritis.
Cochrane T; Davey RC; Matthes Edwards SM
Health Technol Assess; 2005 Aug; 9(31):iii-iv, ix-xi, 1-114. PubMed ID: 16095546
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical and economic outcomes of a short-term physical activity program in knee osteoarthritis patients.
Silva GS; Sullivan JK; Katz JN; Messier SP; Hunter DJ; Losina E
Osteoarthritis Cartilage; 2020 Jun; 28(6):735-743. PubMed ID: 32169730
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness and Budget Impact of Lumacaftor/Ivacaftor in the Treatment of Cystic Fibrosis.
Vadagam P; Kamal KM; Covvey JR; Giannetti V; Mukherjee K
J Manag Care Spec Pharm; 2018 Oct; 24(10):987-997. PubMed ID: 30247102
[TBL] [Abstract][Full Text] [Related]
17. Budget Impact of Adding Ivabradine to Standard of Care in Patients with Chronic Systolic Heart Failure in the United States.
Borer JS; Kansal AR; Dorman ED; Krotneva S; Zheng Y; Patel HK; Tavazzi L; Komajda M; Ford I; Böhm M; Kielhorn A
J Manag Care Spec Pharm; 2016 Sep; 22(9):1064-71. PubMed ID: 27579829
[TBL] [Abstract][Full Text] [Related]
18. Impact of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine use in wound management on health care costs and pertussis cases.
Talbird SE; Graham J; Mauskopf J; Masseria C; Krishnarajah G
J Manag Care Spec Pharm; 2015 Jan; 21(1):88-99, 99a-c. PubMed ID: 25562776
[TBL] [Abstract][Full Text] [Related]
19. The Collaborative Lifestyle Intervention Program in Knee Osteoarthritis Patients (CLIP-OA) trial: Design and methods.
Focht BC; Rejeski WJ; Hackshaw K; Ambrosius WT; Groessl E; Chaplow ZL; DeScenza VR; Bowman J; Fairman CM; Nesbit B; Dispennette K; Zhang X; Fowler M; Haynam M; Hohn S
Contemp Clin Trials; 2022 Apr; 115():106730. PubMed ID: 35283261
[TBL] [Abstract][Full Text] [Related]
20. Bariatric Surgery Coverage: a Comprehensive Budget Impact Analysis from a Payer Perspective.
Palli SR; Rizzo JA; Heidrich N
Obes Surg; 2018 Jun; 28(6):1711-1723. PubMed ID: 29468360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
